Picture of RNA shapes

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

Find out about how advances in oligonucleotide design and delivery are enabling the development of antisense and siRNA-based therapeutics for metabolic diseases in this Review in the June issue

  • Algera Goga
  • Markus Stoffel
Review Article


  • Image of RNA

    As RNA medicines continue to change the face of clinical practice, this conference explores progress in our understanding of the roles of RNAs in immune signaling, chronic disease associated with dysregulated inflammation and efforts to translate basic knowledge into mRNA vaccines and oligonucleotide treatment

  • Picture of poster

    Following the landmark approval of imatinib two decades ago, over 70 kinase inhibitors are transforming the treatment of cancer and other disorders. This poster highlights key advances in this period, including the increased molecular and structural understanding of kinases and strategies to combat resistance to kinase inhibitors in cancer therapy.


Nature Careers